Autolus Therapeutics Reports Third Quarter 2019 Financial Results and Operational Progress
07. November 2019 07:06 ET
|
Autolus Therapeutics plc
LONDON, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced...